In metabolic diseases like obesity and type 2 diabetes, therapies aimed at enhancing lipid oxidation in mitochondria or reducing lipid accumulation in LDs could improve insulin sensitivity and glucose homeostasis. The gene discussed is INS; the disease is obesity disorder.